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Abstract
Background: Obesity is associated with inflammation of visceral adipose tissues, which increases the risk for insulin
resistance. Animal models suggest that T-lymphocyte infiltration is an important early step, although it is unclear why these
cells are attracted. We have recently demonstrated that dietary triglycerides, major components of high fat diets, promote
intestinal absorption of a protein antigen (ovalbumin, ‘‘OVA’’). The antigen was partly transported on chylomicrons, which
are prominently cleared in adipose tissues. We hypothesized that intestinally absorbed gut antigens may cause T-
lymphocyte associated inflammation in adipose tissue.
Methodology/Principal Findings: Triglyceride absorption promoted intestinal absorption of OVA into adipose tissue, in a
chylomicron-dependent manner. Absorption tended to be higher in mesenteric than subcutaneous adipose tissue, and was
lowest in gonadal tissue. OVA immunoreactivity was detected in stromal vascular cells, including endothelial cells. In OVA-
sensitized mice, OVA feeding caused marked accumulation of CD3+ and osteopontin+ cells in mesenteric adipose tissue.
The accumulating T-lymphocytes were mainly CD4+. As expected, high-fat (60% kCal) diets promoted mesenteric adipose
tissue inflammation compared to low-fat diets (10% Kcal), as reflected by increased expression of osteopontin and
interferon-gamma. Immune responses to dietary OVA further increased diet-induced osteopontin and interferon-gamma
expression in mesenteric adipose. Inflammatory gene expression in subcutaneous tissue did not respond significantly to
OVA or dietary fat content. Lastly, whereas OVA responses did not significantly affect bodyweight or adiposity, they
significantly impaired glucose tolerance.
Conclusions/Significance: Our results suggest that loss or lack of immunological tolerance to intestinally absorbed T-
lymphocyte antigens can contribute to mesenteric adipose tissue inflammation and defective glucose metabolism during
high-fat dieting.
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Introduction
Obesity is an important component of the metabolic syndrome
[1] and represents a strong risk factor for cardiovascular disease
[2]. Obesity is associated with inflammatory responses in adipose
tissues [3], and such tissues may affect systemic inflammation
through the release of a pro-inflammatory cocktail of cytokines
and chemokines. Visceral fat tissues are particularly involved in
metabolic defects during obesity [4], and inflammation in visceral
fat may drive part of the metabolic syndrome [5,6]. Besides
affecting whole body metabolism, inflammation in visceral fat
tissue is also commonly associated with Crohn’s Disease, a chronic
inflammatory affliction of the gastro-intestinal tract [7,8]. Given
the strong association of visceral fat inflammation with metabolic
disorders and with inflammatory bowel diseases, it is of crucial
importance to elucidate how and why expanding adipose tissues
become inflamed.
Studies with mice on high-fat diets have demonstrated that
expanding adipose tissues become infiltrated with macrophages,
which may be responsible for most of the inflammatory events in
these tissues [9,10]. However, the infiltration of macrophages is a
relatively late event in diet-induced obesity, and their accumula-
tion is preceded by the accumulation of T-lymphocytes [11].
These infiltrating cells may play an important role in the
recruitment of macrophages [12] and in the regulation of the
inflammatory response [13,14].
Whereas the discovery of the involvement of lymphocytes,
macrophages, and other immune cells, such as mast cells [15], in
adipose tissue inflammation in obesity has led to an increasingly
detailed description of adipose tissue inflammation, it is still not
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causal factors has mainly been on endogenous or dietary factors,
such as saturated fatty acids [16,17]. However, it is now clear that
the intestinal microflora is of pivotal importance in obesity and
metabolic syndrome [18,19,20], perhaps by affecting dietary
energy harvest [18]. Another possibility is that high fat diets, which
exert important stress to the intestinal epithelium [21], promote
the intestinal absorption of antigenic material from the gut, which
then could induce inflammatory immune responses, especially in
tissues in close proximity to the gut. We have previously
demonstrated that intestinal absorption of dietary fat promotes
the absorption of gut-derived lipopolysaccharides (LPS) and of a
protein antigen (ovalbumin; OVA), and both were significantly
associated with chylomicrons [22,23]. Since chylomicrons are
cleared in part in adipose tissue [24,25], we tested, in the present
study, whether fat absorption also promotes OVA absorption into
adipose tissues, and whether this can promote T-lymphocyte
responses and inflammation.
We observed that fat absorption indeed promoted antigen
absorption into adipose tissue. Moreover, mice previously
sensitized to the antigen showed significant inflammatory
responses in mesenteric, but not subcutaneous, adipose tissues,
and these responses were further enhanced during high-fat dieting.
Over time, these responses resulted in a decrease of glucose
tolerance. We propose that intestinal antigen absorption may be a
contributor to inflammation of visceral adipose tissue during high-
fat feeding.
Materials and Methods
Materials, reagents
Medium-chain triglyceride (MCT) oil was from Novartis, the
long-chain triglyceride (LCT) consisted of food grade soybean oil.
Intralipid (20%) was from Glaxo-Welcome. Pluronic L-81, a
surfactant blocking chylomicron secretion from enterocytes at
pharmacological dose [26], was a generous gift from BASF
corporation (Florham Park, NJ). Diets were custom prepared by
Research Diets Inc., based on the D12450B low-fat (10 kcal% fat)
or D12492 high-fat (60 kcal% Fat) diets, and were modified by
exchanging 5% of the dietary protein with egg white for a final
OVA content of 1% by weight. Anti-CD3 was from Abcam
(ab5690), and was visualized in immunohistochemistry with Alexa-
Red 568-labeled goat anti-rabbit IgG from Invitrogen (A-11011).
The anti-osteopontin antibody was from R&D Systems (AF808)
and was visualized by diaminobenzamidine staining using an anti-
goat ABC kit from Pierce. Alexa-488, Alexa-647, and PE-labeled
anti-mouse CD3, CD4, and CD8 antibodies and their isotype
controls were from BioLegend. Ovalbumin (Sigma-Aldrich Grade
V) was radiolabeled with
125-I as described elsewhere [22].
Mice
Male BALB/C mice and C57Bl/6 mice, ordered at 6 weeks of
age from The Jackson Laboratory, were held in a room of a
specific pathogen-free animal facility with a 12 h light/dark cycle,
and were used at 8 weeks of age. For OVA absorption
experiments, mice were fasted (4 h), then gavaged with
125I-
OVA in various vehicles (0.2 ml). Tissues were harvested from
humanely killed mice, after cardiac perfusion with 10 ml cold
phosphate-buffered saline (PBS; except for immunohistochemistry
experiments). For feeding experiments, OVA-naı ¨ve mice were
sensitized by two intraperitoneal injections with 10 mg OVA in
0.2 ml alum (Accurate Chemical and Scientific Corp.), with one
week between injection. Control mice were injected with alum
only. Mice received OVA-containing diets one week after the
second injection for indicated durations. For glucose tolerance
tests, mice were fasted (4 h) before being intraperitoneally injected
with 2 g glucose in PBS/kg bodyweight. Blood samples were
obtained from the tail vein at several time points and were tested
for glucose concentration with a TrueTrack glucose meter from
Home Diagnostics Inc. Adiposity was measured using a
EchoMRI-5000 Whole Body Composition machine (Echo Med-
ical System, Houston, TX). All animals were handled in strict
accordance with good animal practice as defined by the relevant
national and local animal welfare bodies, and all animal work was
approved by the Institutional Animal Care and Use Committee of
the University of Kentucky (Animal Welfare Assurance Number of
the University of Kentucky A3336-01; U.K. IACUC protocol
2008-0306).
Immunohistochemistry
Adipose tissue samples, isolated while strictly avoiding lymph
node material, were fixed in 10% formalin, embedded in paraffin,
and cut in 5 mm sections. Antigens were retrieved in deparaffi-
nized and rehydrated sections by boiling in citrate buffer (10 mM,
pH 6) for 30 minutes. CD3 was stained by successive incubation
with anti-CD3 and Alexa-568 labeled secondary antibody,
whereupon the slides were mounted in 49,6-diamidino-2-pheny-
lindole- (DAPI) containing mounting medium (Vectashield). The
slides were observed with an Olympus BX51 fluorescence
microscope equipped with a digital camera. Osteopontin (OPN)
was detected by using a chromogenic substrate for the secondary
antibody according to the kit manufacturer’s instructions.
Flow Cytometry
Stromal vascular cells were isolated from adipose tissue by
collagenase digestion as described elsewhere [27]. Fluorescently
labeled antibodies, optimized for concentration and specificity
using isotype controls, were added to the cells, and these were
analyzed, after washing, with a FACScalibur flow cytometer
(Becton Dickinson) in the Microbiology, Immunology and
Molecular Genetics Core facility of the University of Kentucky.
Histograms represent cells gated for lymphocyte phenotype based
on forward and side scatter data. Results were plotted with
GateLogic software, version 305.
Quantitative real-time polymerase chain reactions
RNA from adipose tissue samples was extracted with the Trizol-
reagent based method. RNA was transcribed into cDNA with the
iScript kit from Quanta Biosciences, and the resulting cDNA was
amplified using Quanta Bioscience’s Perfect Sybr mix using a
Biorad iQ5 multicycler. Primer pairs were, in 59-39 direction,
AGC-AAG-AAA-CTC-TTC-CAA-GCA-A/GTG-AGA-TTC-
GTC-AGA-TTC-ATC-CG (OPN), TTG-GCC-AGC-GCC-ATC-
TT/CCT-GTT-GCT-GTA-GCC-GTA-TTC-A (Glyceraldehyde
3-phosphate dehydrogenase (GAPDH)), ATG AAC GCT ACA
CAC TGC ATC/CCATCC TTT TGC CAG TTC CTC
(Interferon gamma (IFNc)), and TTG GCC AGC GCC ATC
TT/TGC CTC CTC CAG AGA GAA GTG (Forkhead Box P3
(FOXP3)).
Statistical Analyses
Comparison of gene expression between naı ¨ve or sensitized
mice on low- or high-fat OVA diets was performed with two-way
ANOVA and Bonferroni’s post-hoc tests using XLstat Software
(Addinsoft SARL). Plasma glucose levels over time were compared
between groups with a linear mixed model using SAS software.
OVA absorption data were tested for statistical significance by
Gut Antigens and Adiposity
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subtype percentages with Student’s T-test, using Graphpad Prism
v5. All bar graphs represent average values 6 S.D.
Results
Adipose tissue contains intestinally absorbed antigen
(OVA)
We have recently demonstrated in experiments with mice that
dietary long-chain triglycerides (LCT) significantly enhanced
intestinal absorption of concomitantly ingested dietary OVA,
and that a significant fraction of the OVA was associated with
chylomicrons [22]. To test whether intestinally absorbed OVA
reaches adipose tissue, a major site of chylomicron clearance
[24,25], we gavaged fasted mice with
125I- OVA in 0.2 ml LCT,
MCT (medium-chain triglycerides), or LCT to which the
chylomicron secretion inhibitor Pluronic L-81 (Pl-81) was added.
We observed that gonadal adipose tissue, isolated 60 minutes after
gavage, contained significantly more
125I when the OVA was
gavaged with LCT compared with MCT or LCT plus Pl-81,
suggesting that chylomicron formation, essential for dietary fat
absorption, promotes absorption of gut antigen into adipose tissue
(Figure 1A).
Next, we attempted to determine the preferential adipose tissue
target for absorbed antigen. Fasted mice received an intragastric
bolus of
125I-OVA in 0.2 ml of 20% Intralipid, and
125I levels were
measured in mesenteric (visceral), gonadal (visceral), and inguinal
(subcutaneous) adipose tissue fifteen minutes after gavage. Pilot
experiments had revealed similar levels of radioactivity in the
tissues 15 minutes and 1 h after gavage. Gonadal adipose tissue
contained the least
125I, and mesenteric adipose tissue the most,
although the difference between mesenteric and subcutaneous fat
did not reach statistical significance (Figure 1B).
We next tested whether the radiolabel in adipose tissue
represented antigenic OVA and not just
125I-breakdown products.
This was done by immunohistochemistry of mesenteric adipose
tissue isolated from OVA-naı ¨ve mice fed with 1% egg white-
enriched diet for two weeks. We observed substantial OVA
staining in the adipose tissue of OVA-fed mice, with most of the
signal in cells of the stromal vascular fraction (SVF; Figure 1D, E).
Mice on high-fat diets seemed to have more pronounced OVA
staining, especially in association with the SVF. The absence of
signal in mice on egg-free standard laboratory diets indicated
staining specificity. Collectively, these data indicate that a fraction
of antigenic material in the gut is absorbed into adipose tissue. The
involvement of chylomicronemia in the process suggests that
Figure 1. Intestinal absorption of dietary antigen (OVA) into adipose tissue. (A) Fasted BALB/c mice (n=4) were gavaged with 0.2 ml LCT,
MCT, or LCT plus the inhibitor of chylomicron formation Pluronic L-81, and identical amounts of
125I-OVA. Gonadal adipose tissue was removed 60
minutes later and radioactivity was measured and normalized to tissue weight. (B) shows appearance of
125I-OVA into indicated adipose tissue
samples 15 minutes after gavage of
125I-OVA in 0.2 ml 20% Intralipid. Asterisks indicate statistically significant differences (P,0.05) by one-way
ANOVA with Bonferroni-adjusted post-hoc tests. (C–E) OVA immunostaining (red signal) in mesenteric adipose tissue of mice on OVA-free diets (C) or
1% OVA diets with low- (D) or high- (E) fat content. Blue signals represent DAPI-stained nuclei. OVA is mainly detectable in apparent endothelial cells,
but staining can also be observed in other SVF cells and adipocytes.
doi:10.1371/journal.pone.0013951.g001
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absorption into adipose tissue.
T-lymphocytes accumulate in adipose tissue in response
to dietary OVA
To test whether gut antigens in adipose tissue can provoke T-
lymphocyte responses, we fed OVA-sensitized or OVA-naı ¨ve
BALB/c mice a diet enriched with 1% egg white for two weeks.
Mesenteric adipose tissue samples, isolated after removing the
lymph nodes, were embedded in paraffin for sectioning and
staining with anti-CD3. Whereas CD3+ cells were barely
detectable in mesenteric adipose tissue from OVA-naive mice
(Figure 2A,B), such cells were present in the tissue of sensitized
mice, either in clusters (Figure 2E) or more dispersed throughout
the tissue (Figure 2D). All of the 3 sensitized mice that were thus
analyzed, but none of the three naı ¨ve mice, contained several
CD3+ cell clusters. CD3 immunostaining in OVA-sensitized mice
on OVA-free diets was not different from that in naı ¨ve mice (not
shown).
To determine whether the T-lymphocytes were CD4+ or
CD8+, we fed naı ¨ve or sensitized C57Bl/6 mice with 1% OVA-
containing high-fat diets for 14 weeks and isolated the SVF from
their mesenteric adipose tissue for flow-cytometry. As shown in
Figure 3, the SVF lymphocyte fraction of sensitized mice showed
significant increases in the number of CD3+ cells, with the
majority being accounted for by CD4 T-lymphocytes. Thus, it
appears as if antigen-sensitized mice show increased CD4 T-
lymphocyte infiltration into antigen-containing mesenteric adipose
tissues.
The apparent T-lymphocyte response to gut antigens prompted
us to investigate whether the adipose tissue was inflamed. We used
immunohistochemistry to determine whether the apparent T-
lymphocyte clusters expressed osteopontin. This pro-inflammatory
protein is produced by several cells, including T-lymphocytes (it is
also referred to as Early T Lymphocyte Activation 1; Eta-1), and
has been implicated in adipose tissue inflammation in diet-induced
obesity [27]. Similar to our findings with CD3, we did not detect
osteopontin-expressing cells in adipose tissue from OVA-fed,
Figure 2. Expression of CD3 and osteopontin in mesenteric fat in response to dietary antigen. Naı ¨ve mice (A–C) or OVA-sensitized mice
(D–F) were fed 1% egg-white diets for two weeks, and mesenteric adipose tissue was stained for CD3 (Panels A,B, D, E; red signal) or osteopontin (C, F;
brown signal). Nuclei in A,B,D and E were stained blue with DAPI.
doi:10.1371/journal.pone.0013951.g002
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apparent T-lymphocytes present in mesenteric adipose tissue of
OVA-fed, OVA-sensitized mice showed considerable reactivity
with anti- osteopontin-antibodies (Figure 2F). Thus, the apparent
accumulation of T-lymphocytes in mesenteric adipose tissue was
associated with increased expression of pro-inflammatory
osteopontin.
Increased inflammatory gene expression in mesenteric,
but not subcutaneous adipose tissue in OVA-sensitized
OVA-fed mice
To further investigate the potential contribution of T-lympho-
cyte responses to intestinally absorbed antigens in adipose tissue
inflammation, we fed OVA-naı ¨ve or OVA-sensitized mice with
low- or high- fat diets containing 1% egg-white powder.
Mesenteric and inguinal adipose tissue samples were obtained
after two or ten weeks. As expected, osteopontin gene expression
increased significantly in mesenteric adipose tissue in mice on
high-fat diets. Differences were already apparent after two weeks.
However, osteopontin expression in subcutaneous fat was not
significantly affected by dietary fat content (Figure 4). These
observations are in line with the notion that visceral fat is more
readily inflamed in diet-induced obesity than subcutaneous fat
[4,5,6]. Strikingly, mice responding to the absorbed gut antigen
(OVA sensitized mice) showed even higher osteopontin gene
expression in their mesenteric fat. Similar results were observed
with interferon gamma, another Th1 cytokine implicated in
adipose tissue inflammation in diet-induced obesity [28], except
that the difference was no longer apparent after 10 weeks. This
could be due to the fact that the expression of FOXP3 (Forkhead
Box P3), a marker for regulatory T-lymphocytes, was upregulated.
This observation confirms that T-lymphocytes accumulate in
mesenteric fat (since FOXP3 is restricted to T-lymphocytes) and
indicates that mechanisms are mounted to suppress OVA-driven
inflammation.
Effect of antigen-driven inflammatory immune responses
in adipose tissue on bodyweight, adiposity, and glucose
tolerance
To test the physiological implications of apparent inflammatory
immune responses to gut antigens in adipose tissue, we sensitized
BALB/c mice with OVA plus alum or with alum only (control)
and fed them low or high-fat diets enriched with 1% OVA. Both
naı ¨ve and sensitized mice (n=6 per group) showed similar weight
Figure 3. CD4 T-cell accumulation in mesenteric adipose tissue of OVA-fed, OVA sensitized mice. Naı ¨ve or OVA-sensitized C57Bl/6 mice
were fed 1% OVA-containing high-fat diets for 14 weeks and SVF cells from their mesenteric adipose tissue were analyzed by flow cytometry. Two
representative scatter plots are shown (A). The bar graph (B) shows the average percentage CD4 or CD8 T-lymphocytes 6 S.D. (n=5 mice per group).
The asterisk (*) indicates statistically significant differences (P,0.05; Student’s T-test).
doi:10.1371/journal.pone.0013951.g003
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experiment, and total fat weight gain was similar at 2 and 10
weeks (Figure 5). However, glucose tolerance tests of mice on
OVA-containing high fat diets revealed that sensitized BALB/c
mice showed significantly impaired clearance of blood glucose
after 10 and 14 weeks (Figure 6B, C). In C57Bl/6 mice, glucose
tolerance tended to significantly differ after 14 weeks (Figure 6D).
The lack of significance in C57Bl/6 mice may be due to the fact
that blood glucose levels exceeded the detection ceiling of the test
during the first hour.
Figure 4. Inflammatory gene expression in mesenteric and subcutaneous fat in response to gut antigen. OVA-sensitized BALB/c mice
(black bars) or naı ¨ve BALB/c mice (white bars) were fed 1% egg-white-containing low- or high- fat diets for 2 or 10 weeks, and expression of OPN,
IFNc and FOXP3 were measured in mesenteric and subcutaneous adipose tissue. Groups contained five to six mice, and were compared by two-way
ANOVA after log-transformation of the data. Groups not sharing the same letter were considered statistically significantly different by Bonferroni-
adjusted post-hoc tests.
doi:10.1371/journal.pone.0013951.g004
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Mounting evidence indicates that T-lymphocytes are involved
in the early stages of visceral adipose tissue inflammation in diet-
induced obesity. However, it is still unclear why T-lymphocytes
are attracted. In this study, we provide evidence for a potential role
of antigenic material absorbed from the gut in T-lymphocyte
activation in visceral adipose tissue. First, we show that intestinal
absorption of dietary fat also stimulates the intestinal absorption of
a gut antigen, ovalbumin (OVA), into adipose tissue. Second, we
show that under conditions of lack of immunological tolerance to
such an antigen, mesenteric adipose tissue is a site of T-
lymphocyte dependent inflammation. Third, we show that
prolonged exposure to an antigenic insult from the gut can lead
to a loss of glucose tolerance, an important feature of metabolic
syndrome. Taking these observations into consideration, we
propose that T-lymphocyte activation in visceral adipose tissue
during diet-induced obesity could be, at least in part, a response to
influx of antigenic material absorbed from the gut.
Central adiposity is an important component of metabolic
syndrome. The problem with expanded visceral fat is that it is
frequently inflamed, and this can affect other tissues and lead to
deregulation of lipid and carbohydrate metabolism. A hallmark of
adipose tissue inflammation in diet-induced obesity is the
infiltration of macrophages [9,10]. However, more recent work
has shown that macrophage infiltration occurs relatively late in
diet-induced obesity, and is preceded by T-lymphocytes [11]. CD4
and CD8 T-lymphocytes have since been implicated in macro-
phage recruitment and in the regulation of the inflammatory
response in adipose tissue [12,13,14]. However, these studies still
do not explain why T-lymphocytes are attracted in the first place.
Since excess fat intake is a major cause of obesity in Western
societies, it has been suggested that excess free fatty acids can cause
adipose tissue inflammation through activation of innate immune
receptors [16,17]. However, high-fat diets fail to induce obesity
and the associated chronic inflammation in germfree mice
[19,20,29,30]. This prompted us to test whether antigen
absorption from the gut could elicit inflammatory immune
responses in visceral adipose tissue, and whether excess dietary
fat promotes such responses.
We and others have previously demonstrated that there is a link
between fat absorption and the absorption of bacterial LPS from
the gut [23,31,32]. Interestingly, systemic infusion of absorbed
amounts of LPS in mice was sufficient for diet-induced obesity and
metabolic syndrome, even when the mice were fed standard diets
[32]. We have observed that LPS absorption largely depends on
the formation of chylomicrons, and that these particles contain
most of the absorbed LPS [23]. Since chylomicrons transport
dietary fat to adipose tissue [24,25], these tissues are likely exposed
to considerable amount of LPS. We recently found that a protein
antigen, ovalbumin (OVA), is also increasingly absorbed during
chylomicron formation, and is also associated with these particles
[22]. This may explain why we observed that chylomicron
formation promoted the delivery of dietary OVA to adipose
tissues. Immunohistochemistry suggested that the antigen was
present in several cell types, including adipocytes and SVF cells,
with prominent staining in endothelial cells, which bind chylomi-
crons during lipolytic fatty acid transfer. The fact that chylomicron
formation promotes OVA absorption into adipose tissue suggests
that increased fat intake, which leads to increased postprandial
chylomicronemia, leads to increased antigen exposure of adipose
tissue.
The apparent absorption of an antigen and its uptake into
tissues does not necessarily mean that it will cause inflammatory
Figure 5. No significant effect of immune responses to gut
antigen on body weight or fat mass. Groups of naı ¨ve or sensitized
BALB/c mice (n=6 per group) were fed 1% OVA containing low- or
high- fat diets. Whereas mice on high-fat diets gained more weight than
mice on low-fat diets, there was no significant difference between naı ¨ve
and sensitized mice within each diet group. LF = low-fat diet, HF =
high fat diet, N= naı ¨ve, S= sensitized. (B) Weight gain of body fat (in
grams) of naı ¨ve (white bars) or sensitized (black bars) mice (n=6 per
group) on 1% OVA diets for 2 weeks (B) or 10 weeks (C). Bonferroni-
adjusted post-hoc tests following two-way ANOVA revealed statistically
significant differences between groups not sharing the same letter.
doi:10.1371/journal.pone.0013951.g005
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tolerance to absorbed antigens, which protects against allergic or
inflammatory responses [33]. Indeed, when we fed naı ¨ve mice (i.e.,
mice that were injected intraperitoneally with OVA-free adjuvant)
with OVA-enriched diets, we did not observe T-lymphocyte
infiltration into adipose tissue even though antigen was present.
However, when we sensitized the mice before the feeding started,
we observed significant CD4 T-lymphocyte infiltration into the
tissue. This was associated with an antigen-specific increase in
inflammatory gene expression of mesenteric adipose tissue. In the
early stages of antigen feeding (2 weeks), the apparent inflamma-
tory responses in the adipose tissue did not significantly affect body
weight gain or adiposity, and did also not affect the clearance of
blood glucose. However, after 10 and 14 weeks, the mice displayed
a significant loss of glucose tolerance. The fact that it took so long
for glucose intolerance to occur could perhaps be due to the
concomitant increase in FOXP3 expression in adipose tissue,
which indicates that regulatory T-lymphocytes are present, likely
in an attempt to suppress inflammation.
Our model could be seen as a rather artificial situation, with an
antigen not known to affect obesity and metabolic syndrome and
with an artificially induced immunological sensitivity to the
antigen. Moreover, the mice were sensitized intraperitoneally,
which may have biased the response somehow to the viscera.
Nevertheless, we clearly observed that even OVA-naı ¨ve mice
showed significant inflammation in mesenteric adipose tissue
during high-fat feeding, in contrast to subcutaneous adipose tissue,
which was refractive. We speculate that this difference is due to
increased exposure of mesenteric fat to antigenic material from the
gut. We believe that our work is novel in that it shows, for the first
time (as far as we know), that antigenic material can be absorbed
from the intestine into adipose tissue, and that high-fat diets and
such antigens mutually reinforce mesenteric adipose tissue
inflammation. Since our intestines contain large amounts of
microbial antigens with inflammatory potential, and since their
presence is required for high-fat diet-induced obesity and
metabolic syndrome [19,20,30], it is tempting to speculate that
such antigens can play a role in visceral adipose tissue
inflammation. Antigen absorption and systemic antigen dissemi-
nation certainly do not restrict the antigen to adipose tissue, even
when the antigen is associated with chylomicrons [22]. We
observed substantial antigen accumulation in other tissues, such as
the liver and skeletal muscle. When we looked at the liver, we
found that sensitized mice showed increased OPN expression
during OVA-feeding (unpublished observations). It is possible that
inappropriate responses to gut antigens (perhaps from the
microflora) have deleterious consequences for many physiological
processes.
In summary, we propose a novel mechanism for T-lymphocyte
dependent mesenteric adipose tissue inflammation in obesity:
High-fat diets promote intestinal absorption of gut antigens, and
the delivery of the antigens to adipose tissues, preferentially
visceral depots. This leads to early infiltration of T-lymphocytes
into the tissue. A pro-inflammatory milieu within the visceral fat,
Figure 6. Inflammatory immune responses to gut antigen in mesenteric adipose tissue impair glucose tolerance. OVA-sensitized (solid
lines and symbols) or naı ¨ve (dashed lines, open symbols) mice were put on 1% OVA-containing high-fat diets for the indicated duration, and a
glucose tolerance test was then performed on fasted mice. Glucose clearance was significantly impaired in sensitized BALB/c mice after 10 and 14
weeks (linear mixed model test for identical trajectories) and trended to significantly decrease in C57Bl/6 mice after 14 weeks.
doi:10.1371/journal.pone.0013951.g006
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risk for loss of tolerance to the antigens, favoring chronic
inflammation.
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